Duodenal Ulcer
📧 Sign up to get email alerts when something new happens for Duodenal Ulcer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-04Clinical Trial Update: A Study of Esomeplazole (D961H) in Japanese Paediatric Patients With Reflux Esophagitis, Gastric Ulcer or Duodenal Ulcer [Phase 3]
A Phase 3 trial of Esomeplazole (D961H) in Japanese pediatric patients with reflux esophagitis, gastric ulcer, or duodenal ulcer has complet…
-
CLINICAL_TRIALS trial_result · 2023-04-25Clinical Trial Update: Efficacy and Safety of LXI-15028 Comparing With Lansoprazole in the Treatment of Duodenal Ulcer [Phase 3]
A Phase 3 trial comparing LXI-15028 with lansoprazole for duodenal ulcer has completed, evaluating efficacy and safety.
-
CLINICAL_TRIALS trial_result · 2021-05-19Clinical Trial Update: Special Drug Use Surveillance of Vonoprazan for "Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs: Long-term Use"
Completed long-term surveillance trial evaluating vonoprazan for prevention of recurrence of gastric/duodenal ulcers in NSAID users; results…
-
CLINICAL_TRIALS trial_result · 2021-03-18Clinical Trial Update: Helicobacter Pylori Eradication With a New Sequential Treatment [Phase 3]
Phase 3 trial update on a new sequential treatment for Helicobacter pylori eradication completed.
-
CLINICAL_TRIALS trial_result · 2020-08-07Clinical Trial Update: A Phase 2 Randomised Controlled Trial to Evaluate Efficacy and Safety of Anaprazole in Patients With Duodenal Ulcers. [Phase 2]
A Phase 2 randomized trial evaluated the efficacy and safety of Anaprazole in patients with duodenal ulcers; study completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-06-12Clinical Trial Update: Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Duodenal Ulcer Participants With or Without Helicobacter Pylori Infection [Phase 3]
Phase 3 trial comparing TAK-438 (Vonoprazan) to Lansoprazole in duodenal ulcer treatment, with or without Helicobacter pylori infection; stu…
-
CLINICAL_TRIALS trial_result · 2020-01-02Clinical Trial Update: A Phase 3 Randomised Controlled Trial to Evaluate Efficacy and Safety of Anaprazole in Patients With Duodenal Ulcers. [Phase 3]
A Phase 3 randomized trial evaluating the efficacy and safety of anaprazole for duodenal ulcers is ongoing with unknown status.
-
CLINICAL_TRIALS trial_result · 2019-12-12Clinical Trial Update: Drug Use Surveillance of Vonoprazan for "Gastric Ulcer, Duodenal Ulcer, and Reflux Esophagitis"
A completed clinical trial update for vonoprazan assessing gastric ulcer, duodenal ulcer, and reflux esophagitis with results posted in 2019…
-
CLINICAL_TRIALS trial_result · 2019-02-27Clinical Trial Update: Cytoprotective Agent and Peptic Ulcer in Dual Antiplatelet :RCT [Phase 2, Phase 3]
A randomized trial update on a cytoprotective agent for preventing gastric and duodenal ulcers induced by antiplatelet therapy, with Phase 2…
-
CLINICAL_TRIALS trial_result · 2018-07-10Clinical Trial Update: Efficacy of Low Dose of Proton Pump Inhibitor in Treatment Bleeding Ulcers
This completed trial evaluated the efficacy of a low-dose proton pump inhibitor for the treatment of bleeding ulcers, including marginal ulc…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Effect of Second-look Endoscopy on Peptic Ulcer Rebleeding in Patients With Early Resumption of Antiplatelet Agents [NA]
Terminated clinical trial evaluating if second-look endoscopy reduces peptic ulcer rebleeding in patients who resume antiplatelet therapy ea…
-
CLINICAL_TRIALS trial_result · 2017-07-13Clinical Trial Update: Comparative Bioavailability Study of Two Test Products of Fixed Dose Combination Capsule of Acetylsalicylic Acid (ASA) and Pantoprazole (Each Capsule Contains ASA 100 mg and Pantoprazole 20 mg) Under Fed Conditions [Phase 1]
This Phase 1 trial compared the bioavailability of two test products of a fixed-dose combination capsule containing aspirin 100 mg and panto…
-
CLINICAL_TRIALS trial_result · 2017-07-13Clinical Trial Update: Comparative Bioavailability Study of Two Test Products of Fixed Dose Combination Capsule of ASA (Acetylsalicylic Acid) and Pantoprazole (Each Capsule Contains ASA 100 mg and Pantoprazole 20 mg) Under Fasting Conditions [Phase 1]
Phase 1 bioavailability study comparing two test products of a fixed-dose capsule containing acetylsalicylic acid 100 mg and pantoprazole 20…
-
CLINICAL_TRIALS trial_result · 2017-01-19Clinical Trial Update: A Phase I/III Study of D961H 10 mg and 20 mg in Japanese Paediatric Patients With Gastrointestinal Acid Related Diseases [Phase 3]
Phase III results for D961H at 10 mg and 20 mg in Japanese pediatric patients with gastrointestinal acid-related diseases have been complete…
-
CLINICAL_TRIALS trial_result · 2016-07-28Clinical Trial Update: Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients [Phase 2, Phase 3]
This update reports the completion of Phase 2 and Phase 3 trials assessing ilaprazole for treating duodenal ulcer in Chinese patients.
-
CLINICAL_TRIALS trial_result · 2016-04-11Clinical Trial Update: Clinical Trial Evaluating Gastrointestinal Damage Following Administration PL3100 or Naproxen in At-Risk Adults [Phase 2]
A Phase 2 trial evaluated gastrointestinal damage after administration of PL3100 versus naproxen in at-risk adults; results have been posted…
-
CLINICAL_TRIALS trial_result · 2016-02-23Clinical Trial Update: Lansoprazole Intravenous 30 mg Specified Drug-use Survey [Hemostatic Effect/Rebleeding Rate]
Completed clinical trial update evaluating intravenous lansoprazole 30 mg for hemostatic effects and rebleeding rates in gastric and duodena…
-
CLINICAL_TRIALS trial_result · 2015-11-16Clinical Trial Update: Long-term Prevention of Recurrent Gastric or Duodenal Ulcers Caused by Low-dose Aspirin With Rabeprazole (E3810) Treatment (Planetarium Study) [Phase 2, Phase 3]
The Planetarium Study, a Phase 2/3 trial, reports completed results on using rabeprazole to prevent recurrence of aspirin-induced gastric an…
-
CLINICAL_TRIALS trial_result · 2015-10-09Clinical Trial Update: Long-term Use of Takepron on the Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs
A completed Takeda trial evaluated long-term Takepron for preventing recurrence of NSAID-associated gastric or duodenal ulcers; results were…
-
CLINICAL_TRIALS trial_result · 2015-06-25Clinical Trial Update: Long-term Use of Takepron Capsules on the Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Low-dose Aspirin
A completed Takeda trial evaluating long-term use of Takepron capsules to prevent recurrence of gastric and duodenal ulcers in patients taki…
-
CLINICAL_TRIALS trial_result · 2015-06-11Clinical Trial Update: MK0782 + Low-Dose Aspirin 7-Day Erosion Endoscopy Study (0782-001) [Phase 2]
A Phase 2 trial (0782-001) evaluating MK0782 with low-dose aspirin for a 7-day erosion endoscopy in gastric and duodenal ulcers has complete…
-
CLINICAL_TRIALS trial_result · 2014-04-16Clinical Trial Update: Nexium Capsules Clinical Experience Investigation
Nexium (esomeprazole) capsules completed a clinical experience investigation. The study covered gastric and duodenal ulcers, anastomotic ulc…
-
CLINICAL_TRIALS trial_result · 2014-04-16Clinical Trial Update: Nexium Capsules Helicobacter Pylori Specific Clinical Experience Investigation
A completed trial update evaluating Nexium (esomeprazole) for Helicobacter pylori–specific clinical experience across several gastric diseas…
-
CLINICAL_TRIALS trial_result · 2014-04-09Clinical Trial Update: Efficacy and Safety of L-Pantoprazole Sodium Injection to Treat Upper Gastrointestinal Ulcer Bleeding [NA]
An update on a clinical trial evaluating the efficacy and safety of L-Pantoprazole Sodium Injection for upper gastrointestinal ulcer bleedin…
-
CLINICAL_TRIALS trial_result · 2014-02-10Clinical Trial Update: A Unblinded Study of TAK-438 (20 mg) for Prevention of Recurrence of Gastric or Duodenal Ulcer During Long-Term Low-Dose Aspirin Therapy [Phase 3]
This Phase 3 unblinded trial evaluated TAK-438 (20 mg) for preventing recurrence of gastric or duodenal ulcers in patients on long-term low-…